trial
as of 2026-07-01Bergen Psychosis Project 2 - The Best Intro Study
NCTId NCT01446328
at a glance
Phase 4 · Completed
Enrollment 151 (actual)
Sponsored by Haukeland University Hospital
Primary completion 2017-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
151 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2011-10
Primary completion
2017-12
Eligibility
ALL · 16 Years
Interventions & indications
Sponsors
Haukeland University HospitalLead Sponsor
Helse VestCollaborator
Investigators
1
Erik Johnsen, M.D., Ph.D.Principal Investigator
Sites
4 total
Innsbruck, AustriaBergen, NorwayStavanger, NorwayTrondheim, Norway
Facts & assertions
4 sourced
Enrollment
151
Phase
PHASE4
Primary Completion Date
2017-12
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
company
indication
investigator